Clinical trial
Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating…
NCT00019760 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00019760 |
|---|---|
| Title | Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver |
| Official title | Phase II Study of Isolated Hepatic Perfusion With Melphalan Followed By Postoperative Hepatic Arterial Chemotherapy in Patients With Unresectable Colorectal Cancer Metastatic to the Liver |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Colon Cancer, Liver Metastases, Stage IV Rectal Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer |
| Intervention type | Drug |
| Interventions | floxuridine, leucovorin calcium, melphalan |
| Start date | Apr 1, 1999 |
| Completion | Mar 1, 2002 |
| First posted | Mar 5, 2007 |
| Last update posted | Oct 31, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: